The long-term objective of this proposal is to determine the role of TGF-b in bone formation through the regulation of mesenchymal stem/progenitor cells (MSCs) proliferation and osteoblastic differentiation. Accumulating evidence strongly supports the notion that TGF-b plays a very important role in bone formation, resorption, and repair. In both in vivo and in vitro model systems, TGF-b exhibits potent effects on multiple functions of bone cells. The signaling mechanisms underlying the complex activities of TGF-b on bone remodeling, however, remain largely unknown. Recently, we found that Smad3-deficient animals develop an osteopenic phenotype, thus providing direct evidence supporting the hypothesis that Smad3 acts as an important mediator for TGF-b in bone formation and metabolism. More importantly, we have made a highly significant finding that TGF-b induces b-catenin nuclear translocation in MSCs, suggesting that cross-talk between the TGF-b and Wnt signaling pathways plays a critical role in regulating the proliferation and differentiation of bone marrow-derived MSCs which can differentiate into osteoblasts. To investigate the mechanism by which TGF-b regulates proliferation and osteoblastic differentiation of MSCs, we will focus on two Specific Aims.
For Aim 1, we will test the hypothesis that modulation of the localization and activity of b-catenin by TGF-b in the specific cellular context of MSCs represents the underlying mechanism by which TGF-b promotes the proliferation of those cells. We will determine if the pro-proliferation activity of TGF-b depends on the nuclear translocation of b-catenin and whether the presence of autocrine Wnt signaling and/or the absence of cadherin expression constitute the unique cellular context of MSCs.
For Aim 2, we will focus on elucidation of the molecular mechanism underlying the activation of the TGF-b receptors and the mobilization of b-catenin into the nucleus. Specifically, we will determine if the induction of b-catenin nuclear translocation is a Smad-dependent process and examine the structural requirement for the interaction between Smads and b-catenin. Bone formation and repair is a complex process modulated by multiple factors, including TGF-b and its family members. Thus, the accomplishment of these proposed studies will provide further understanding of the molecular mechanism by which TGF-b regulates bone remodeling and contribute to the development of novel therapeutics for the treatment of human bone diseases. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK064113-03
Application #
6984121
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Malozowski, Saul N
Project Start
2004-01-01
Project End
2007-12-31
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
3
Fiscal Year
2006
Total Cost
$247,376
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Guo, Xing; Wang, Xiao-Fan (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19:71-88
Ma, Chaoyu; Rong, Yu; Radiloff, Daniel R et al. (2008) Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22:308-21
Guo, Xing; Ramirez, Alejandro; Waddell, David S et al. (2008) Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev 22:106-20
Guo, X; Waddell, D S; Wang, W et al. (2008) Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling. Oncogene 27:7235-47
Jian, Hongyan; Shen, Xing; Liu, Irwin et al. (2006) Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20:666-74
Hjelmeland, Anita Borton; Schilling, Stephen H; Guo, Xing et al. (2005) Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination. Mol Cell Biol 25:9460-8